Tab Article
Rh-isoimmunization is the most common cause of fetal anemia. The problem of Rh-isoimmunization has been the most
challenging and yet intrauterine transfusion for fetal anemia, the most rewarding therapy in fetal medicine. Despite national
recommendations and standard protocols for RhD immune prophylaxis, the incidence still remains high. This Focus aims to
cover all aspects of Rh-isoimmunization in a brief and concise manner and easy-to-comprehend flow of topics with emphasis on
Prophylaxis, Investigation and Treatment algorithms. It also covers the neonatal aspects of the affected fetuses, their potential
long-term outcomes, and issues such as recurrent hydrops which can be clinically challenging. The promising and potential role
of noninvasive prenatal testing and the newer treatment methods have also been discussed.
Isha Mittal
Verified PurchaseThe customer care service is quite responsive. I was having an issue while making a bulk order. I contacted the customer support and they helped me instantly.